Publications

18

Apr, 2003

Pharmacokinetics of Nelfinavir and its Active Metabolite, hydroxy-tert-butylamide, in Infants Perinatally Infected with HIV-1.

 

Authors: Litalien C, Faye A, Compagnucci A, Giaquinto C, Harper L, Gibb DM, Jacqz-Aigrain E for PENTA.

Published in: Pediatr Inf Dis J 2003; 22(1):48-55

Read

18

Apr, 2003

Three year follow-up of the PENTA 5 trial.

 

Authors: Gibb DM, Giaquinto C, Walker AS, Harper L, Compagnucci A, Saidi Y, Moulinier C, Aboulker JP, Babiker AG, Debré M, Darbyshire JH on behalf of the PENTA 5 Executive Committee

Published: 10th Conference on Retroviruses and Opportunistic Infections February 10th – 14th, 2003 – Boston. Poster G1-12

Read

18

Apr, 2003

Relationship between Cell-Associated HIV-1 DNA and Thymic Output in HIV-1 infected Children Initiating Antiretroviral Therapy in the PENTA 5 Trial

 

Authors: De Rossi A, Walker AS, De Forni D, Gibb DM on behalf of PENTA.

Published in: 10th Conference on Retroviruses and Opportunistic Infections February 10th – 14th, 2003 – Boston. Poster P-17

Read

18

Apr, 2003

Adherence to Prescribed Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Children in the PENTA 5 Trial.

 

Author: Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H for PENTA.

Published in: Pediatr Inf Dis J 2003; 22 (1): 56-62

Read

18

Sep, 2002

Zidovudine (ZDV) appears to prevent selection of K65R and L74V, mutations normally selected by Abacavir (ABC) mono- or combination therapies not containing ZDV.

 

Authors: Ait-Khaled M, Lanier R, Richards N, Stone C, Griffin P, Gibb DM, Walker AS, Craig C, Loeliger E, Tisdale M

Published in: 2002 International Meeting of the Institute of Human Virology, September 9-13, 2002, Baltimore

18

Jul, 2002

Adherence to HAART in children: results from a questionnaire study of children in PENTA 5 trial.

 

Authors: Giacomet V, Gibb DM, Goodall R, McGee L, Walker AS, Giaquinto C.

Published in: XIV World AIDS Conference, Barcelona, Spain, 7-12 July 2002. Poster TuPpB2050)

Read

18

Jul, 2002

96 week follow-up of the PENTA 5 trial; comparing ZDV+3TC, ZDV+ABC and 3TC+ABC with or without NFV in ART naive children

 

Authors: Gibb DM, Walker AS, Giaquinto C, Harper L, Compagnucci A, Saidi Y, Aboulker JP, Babiker A, Debré M, Darbyshire JH on behalf of the PENTA 5 Steering Committee.

Published in: XIV World AIDS Conference, Barcelona, Spain, 7-12 July 2002. Poster TuPpB2051)

Read

19

Apr, 2002

PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection.

 

Authors: Sharland M, Castelli Gattinara G, Tomas Ramos J, Blanche S, Gibb DM for the PENTA Steering Committee.

Published in: HIV Med 2002; 3:215-226

18

Apr, 2002

Biphasic decay of cell-associated HIV-1 DNA in HIV-1 infected children on antiretroviral therapy.

 

Authors: De Rossi A, Walker AS, De Forni D, Gibb DM for PENTA

Published in: Research Letter in AIDS 2002; 16:1961-6

Read

18

Apr, 2002

Impact of HIV-1 subtypes on virologic response and emergence of drug resistance.

 

Authors: Pillay D, Walker AS, Gibb DM, De Rossi A, Kaye S, Ait-Khaled M, Muñoz-Fernandez M, Babiker A. for the PENTA Steering Committee.

Published in: J Infect Dis 2002; 186: 617-25

Read